Pharmacopsychiatry

Papers
(The median citation count of Pharmacopsychiatry is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
28
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?27
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System17
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model16
The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions14
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation14
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment13
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries13
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study12
Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain11
The Mini-TRH Test11
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study11
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not10
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study10
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse9
8
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety8
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control7
News on the Role of Antidepressants in and for COVID-19 and Long COVID7
7
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA7
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS6
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy6
Can Red Blood Cell Membrane Fatty Acids Predict Intracellular Lithium Concentration in Bipolar Disorder? A Cross-Sectional Study6
6
Intestinal Flora and Depression: Interaction Mechanisms and Therapeutic Prospects5
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie5
Patient and Physician Exposure to Artificial Intelligence Hype5
Social Robots in Psychiatry for Patients Suffering from Major Depression—A Pilot Study5
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis4
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case4
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision4
4
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey4
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab3
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use3
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis3
Overview: Chronic Pain and Cannabis-Based Medicines3
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics3
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita3
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy3
Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease3
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye3
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes3
3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?3
Guideline adherence in patients with long-term schizophrenia in Germany: Focus on clozapine and electroconvulsive therapy3
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-C3
Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schiz2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality2
Utilizing Machine Learning to Forecast 3-Month Remission Outcomes in Bipolar Disorder Patients Treated with Lithium2
2
Functional connectivity analysis of locus coeruleus in patients with major depressive episode2
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges2
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others2
Blocking the Reflection: Milestones and Hurdles for Digital Twins in Mental Health2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa2
Metformin is Protective Against the Development of Mood Disorders2
2
Heart Rate-Corrected QT Interval Dynamics Following Antidepressant Switching from Escitalopram to High-Dose Venlafaxine: Cardiac Safety Insights from the Early 2
Impact of Parkinson Medication on Neuropsychiatric and Neurocognitive Symptoms in Patients with Advanced Parkinson Disease Prior to Deep Brain Stimulation1
Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities1
Antidepressant Prescribing Patterns At Initial Visits for Patients With Mild Depression: A Retrospective Study1
Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabil1
Triiodothyronine: Strengthened evening preference in study participants with an ADHD diagnosis1
Antipsychotic Polypharmacy and Epigenetic Age Acceleration in Schizophrenia1
Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?1
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 – Pharmacokinetic, pharmacogenetic and clinical aspects1
Investigation of Stress-Induced Cortisol Effects on Decision Making After Pharmacological Mineralocorticoid or Glucocorticoid Receptor Blockade1
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA1
Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring1
Age-dependent stimulus dose increase during an acute ECT series1
1
1
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme1
Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis1
Comparative study of suggested reference values and observed distributions in daily routine of a medical laboratory1
Traumatic childhood experiences are related to higher hair cortisol in postpartum1
Activation of Hippocampal Neuronal NADPH Oxidase NOX2 Promotes Depressive-Like Behaviour and Cognition Deficits in Chronic Restraint Stress Mouse Model1
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysis0
0
Greater Depressive Symptom Severity is Associated with Increased Odds of Analgesic Use0
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review0
Influence of Glutamate Neurotransmission Genes on the Outcomes of Antipsychotic Treatments0
0
0
Is Lumateperone Effective in Bipolar Depression? A Systematic Literature Review and Meta-Analysis on Placebo-Controlled Trials0
Drawing new lines – Machine-learning guided response prediction and bio-signal analysis of ECT index series0
Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism0
Editorial0
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany0
Early Treatment-Resistance in First Episode Psychosis0
0
Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder0
0
Ensemble Machine Learning Model for Real-Time Valproic Acid Prediction in Epilepsy Treatment0
Strategies and Management for Psychiatric Drug Withdrawal: A Systematic Review of Case Reports and Series0
Interleukine-6 and high-sensitive CRP plasma levels and antidepressant response- A secondary analysis from the Early Medication Change (EMC) trial0
Association of Physical Activity and Bone Mineral Density in Adults with Depressive Symptoms0
Risk Phenotypes, Comorbidities, Pharmacotherapy, and Electroconvulsive Therapy (ECT) in a Cohort with Difficult-to-Treat Depression in Comparison to an Unmedica0
Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multic0
Augmentation of Electroconvulsive Therapy with Oral Caffeine: A Retrospective Analysis of 40 Patients with Major Depression0
Low glucose influences Clock expression in study participants with an ADHD diagnosis0
0
Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties0
0
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy0
0
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy0
Evaluation of E-Cigarette Use in Opioid-Dependent Patients in Maintenance Treatment0
0
Interpersonal Needs, Mental Pain, and Hopelessness in Psychiatric Inpatients with Suicidal Ideation0
Age-dependent sex differences in the association between cortisol concentrations and childhood trauma0
Medical Cannabis in Psychiatry0
Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial0
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammati0
Be Aware of AI Limitations0
Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study0
Processing and recall of safety- and threat cues: The influence of oxytocin and the menstrual cycle0
0
Association of seizure quality markers with postictal autonomic tone—the postictal heart rate correlates with seizure duration in electroconvulsive therapy0
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis0
Instruments Assessing Medication Literacy in Psychiatric Patients and the Caregivers: A Systematic Review0
Great Expectations, Limited Evidence: The Emerging Role of Artificial Intelligence in Pharmacopsychiatry0
Comparable Psychotropic Prescription Rates After Hospital Discharge Between Patients with COVID-19 and Those With Non-COVID-19-Related Respiratory Infection0
0
0
Human Derived Dermal Fibroblasts as in Vitro Research Tool to Study Circadian Rhythmicity in Psychiatric Disorders0
Dose-corrected serum concentrations of antidepressant drugs in patients of a gerontopsychiatric day care unit – Dependence on renal function and multimorbidity?0
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum D0
Cannabinoids for Behavioral Symptoms in Dementia: An Overview0
Correction: Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain0
Efficacy and tolerability of nutraceuticals and phytotherapics for antipsychotic-induced weight gain in schizophrenia spectrum disorders: Systematic review and 0
Patient Perspectives on Pharmacotherapy of Alcohol Dependence0
Clomethiazole for insomnia in older adults: A systematic review and meta-analysis0
„Peter Müller Preis für Forschung im Bereich Schizophrenie“ in Höhe von 5.000€0
Therapeutic Drug Monitoring of Cariprazine – Updated Values for a Dose-Related Reference Range0
A Tribute to Prof. Jules Angst highlighting his Contributions to Clozapine0
0
Correction: Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, R0
Investigation of axonal neurodegeneration in anti-neural autoantibody-associated psychiatric syndromes0
High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients0
Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment0
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial0
How to Improve Methodological Issues in Clinical Trials to Confirm that Pentoxifylline is Useful as an Add-on Therapy for Major Depressive Disorder0
Clomethiazole for the treatment of alcohol withdrawal syndrome: A systematic review and metanalysis0
Cortical and subcortical grey matter volume alterations in neuropsychiatric long-COVID syndrome episode0
Caffeine influences Clock expression in study participants with an ADHD diagnosis0
Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature0
Neurological soft signs are increased in major depressive disorder irrespective of antidepressant treatment0
Valproic Acid Induced Thrombocytopenia in an Elderly Man with Schizoaffective Disorder: A Case Report0
Management of Refractory Functional Gastrointestinal Disorders: What Role Should Psychiatrists Have?0
High Clozapine Serum Levels Do Not Improve Response: An Observational Study in Patients with Schizophrenia Treated with Clozapine in a Naturalistic Setting0
The Effect of Electroconvulsive Therapy on Specific Catatonia Symptoms and Predictors of Late Response0
Therapeutic Reference Ranges for ADHD Drugs in Blood of Children and Adolescents: A Systematic Review by the AGNP TDM-Task Force0
Association of Four Medication Classes and Non-suicidal Self-injury in Adolescents with Affective Disorders – A Retrospective Chart Review0
Positive association between norfluoxetine serum concentration and prolonged QTc intervals in children and adolescents0
Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism0
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature0
CYP2C19 and CYP2D6 genotyping in a cohort of patients with treatment-resistant depression0
Influence of long-term citalopram treatment on the cognitive decline and pathology in a sporadic Alzheimer’s disease mouse model0
Using Classification and Regression Tree Modeling to Investigate the Effects of Subanesthetic Ketamine Infusion on Remission of Suicidal Symptoms0
Therapeutic drug monitoring of venlafaxine in real-world patients: Dose, concentration and therapeutic efficacy0
Advancements in Non-Dopaminergic Treatments for Schizophrenia: A Systematic Review of Pipeline Developments0
Rates of Hypoprolactinemia in Bipolar Patients Receiving Once-monthly Long-acting Injectable Aripiprazole0
Effectiveness of Medical Cannabis for the Treatment of Depression: A Naturalistic Outpatient Study0
Diversion and Abuse of Prescribed Methylphenidate – A Survey of an Outpatient Clinic for Adult Persons with ADHD0
Implications of Online Self-Diagnosis in Psychiatry0
Serious adverse drug reactions to antipsychotics in children and adolescents with multiple disabilities: Avoidability and potential cost savings by therapeutic 0
Establishing Core Symptoms of Acute Serotonin Reuptake Inhibitor Withdrawal: Results from an International Survey of Online Peer-Support Communities0
„AGNP-Preis für Forschung in der Psychopharmakologie“ in Höhe von 5.000 €0
Clinical and Neurobiological Findings in a Patient With Unipolar Depressive 48-hour-ultrarapid-cycling0
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Stu0
A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study0
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point0
Challenges and Ethical Considerations to Successfully Implement Artificial Intelligence in Clinical Medicine and Neuroscience: a Narrative Review0
Cariprazine Orodispersible Tablet: A New Formulation for Cariprazine0
0
A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosi0
Ongoing Changes in Web Searches for Health-Related Information0
Antipsychotic Medication Preferences: A Large-Scale Survey0
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
Discontinuation Rate of Lurasidone and Quetiapine Extended Release in Bipolar Depression0
Lithium Therapy in Old Age: Recommendations from a Delphi Survey0
ADHD and oligoantigenic diet – Feasibility, effectiveness and follow-up0
Clozapine-Induced Stuttering: Case Report and Literature Review0
Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis0
Correction: Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review0
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years0
Pharmacological Treatment of Autism Spectrum Disorder: A Systematic Review of Treatment Guidelines0
Caffeine augmentation in electroconvulsive therapy0
0.33142304420471